ChemicalBook >> CAS DataBase List >>4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-[3-[(4aR,7aS)-hexahydro-6H-1,4-dioxino[2,3-c]pyrrol-6-yl]propoxy]-7-methoxy-, rel-

4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-[3-[(4aR,7aS)-hexahydro-6H-1,4-dioxino[2,3-c]pyrrol-6-yl]propoxy]-7-methoxy-, rel-

CAS No.
1438072-11-7
Chemical Name:
4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-[3-[(4aR,7aS)-hexahydro-6H-1,4-dioxino[2,3-c]pyrrol-6-yl]propoxy]-7-methoxy-, rel-
Synonyms
Larotinib;rel-N-(3-Chloro-4-fluorophenyl)-6-(3-((4aR,7aS)-hexahydro-6H-[1,4]dioxino[2,3-c]pyrrol-6-yl)propoxy)-7-methoxyquinazolin-4-amine;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-[3-[(4aR,7aS)-hexahydro-6H-1,4-dioxino[2,3-c]pyrrol-6-yl]propoxy]-7-methoxy-, rel-
CBNumber:
CB39806080
Molecular Formula:
C24H26ClFN4O4
Molecular Weight:
488.94
MDL Number:
MOL File:
1438072-11-7.mol
MSDS File:
SDS
Last updated:2026-07-27 17:00:41

4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-[3-[(4aR,7aS)-hexahydro-6H-1,4-dioxino[2,3-c]pyrrol-6-yl]propoxy]-7-methoxy-, rel- Properties

Boiling point 628.1±55.0 °C(Predicted)
Density 1.346±0.06 g/cm3(Predicted)
pka 8.06±0.20(Predicted)
form Solid
color White to off-white

4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-[3-[(4aR,7aS)-hexahydro-6H-1,4-dioxino[2,3-c]pyrrol-6-yl]propoxy]-7-methoxy-, rel- price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 44444 Larotinib ≥98% 1438072-11-7 1mg $40 2026-04-30 Buy
Cayman Chemical 44444 Larotinib ≥98% 1438072-11-7 5mg $180 2026-04-30 Buy
Cayman Chemical 44444 Larotinib ≥98% 1438072-11-7 10mg $320 2026-04-30 Buy
Cayman Chemical 44444 Larotinib ≥98% 1438072-11-7 25mg $550 2026-04-30 Buy
ChemScene CS-0650981 Larotinib 99.50% 1438072-11-7 5mg $238 2026-06-04 Buy
Product number Packaging Price Buy
44444 1mg $40 Buy
44444 5mg $180 Buy
44444 10mg $320 Buy
44444 25mg $550 Buy
CS-0650981 5mg $238 Buy

4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-[3-[(4aR,7aS)-hexahydro-6H-1,4-dioxino[2,3-c]pyrrol-6-yl]propoxy]-7-methoxy-, rel- Chemical Properties, Uses, Production

Uses

Larotinib is a potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC50 of 0.6 nM[1].

in vivo

After daily administration of Larotinib mesylate, the no observed adverse effect level (NOAEL) is 10 mg/kg in Sprague-Dawley rats and the lowest observed adverse effect level (LOAEL) is 5 mg/kg in beagle dogs. The maximal tolerable doses (MTDs) are 20 and 25 mg/kg in Sprague-Dawley rats and beagle dogs, respectively[1].
Larotinib mesylate shows dose-dependent antitumor results and a tumor-inhibiting rate exceeding 60% at 18 mg/kg in a tumor-bearing mice model (data not published)[1].

IC 50

EGFRL861Q: 0.423 nM (IC50); EGFRL858R: 0.563 nM (IC50); EGFR (WT): 0.611 nM (IC50); EGFRT790M: 45.2 nM (IC50); HER4: 84 nM (IC50); BLK: 102 nM (IC50); IRAK1: 167 nM (IC50); BTK: 196 nM (IC50); HER2: 253 nM (IC50)

References

[1] Liu J, et al. Phase I Trial to Evaluate the Tolerance, Pharmacokinetics and Efficacy of the Broad-Spectrum ErbB Family Inhibitor Larotinib Mesylate in Patients With Advanced Solid Tumors. Front Pharmacol. 2021 Feb 18;12:636324. DOI:10.3389/fphar.2021.636324

4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-[3-[(4aR,7aS)-hexahydro-6H-1,4-dioxino[2,3-c]pyrrol-6-yl]propoxy]-7-methoxy-, rel- Preparation Products And Raw materials

Raw materials

Preparation Products

4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-[3-[(4aR,7aS)-hexahydro-6H-1,4-dioxino[2,3-c]pyrrol-6-yl]propoxy]-7-methoxy-, rel- Suppliers

Global Suppliers ( 15)
Supplier Tel Email Country ProdList Advantage
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
Tianjin Kailiqi Biotechnology Co., Ltd. 15076683720 klq@cw-bio.com China 9780 55
TargetMol Chemicals Inc. +1-781-999-5354; +1-00000000000 marketing@targetmol.com United States 32431 58
Zhejiang Huida Biotech Co., LTD 0571-89903022 18679456698 zilong@hizyme.com China 8001 58
Beijing Jin Ming Biotechnology Co., Ltd. 010-60605840 psaitong@jm-bio.com China 27626 58
Bide Pharmatech Ltd. 400-1647117 13681763483 product02@bidepharm.com China 59929 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11963 58
Beijing Boorsen Biotechnology Co., Ltd 400-901-9800 18611424007 cis@bioss.com.cn China 9185 58
TargetMol Chemicals Inc. 15002134094 marketing@targetmol.cn China 29874 58
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd 025-5885952 15955137747 sales@aikonchem.com China 8012 58

View Latest Price from 4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-[3-[(4aR,7aS)-hexahydro-6H-1,4-dioxino[2,3-c]pyrrol-6-yl]propoxy]-7-methoxy-, rel- manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Larotinib pictures 2026-07-27 Larotinib
1438072-11-7
$74.00-272.00 99.73% 10g TargetMol Chemicals Inc.
  • Larotinib pictures
  • Larotinib
    1438072-11-7
  • $74.00-272.00
  • 99.73%
  • TargetMol Chemicals Inc.

4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-[3-[(4aR,7aS)-hexahydro-6H-1,4-dioxino[2,3-c]pyrrol-6-yl]propoxy]-7-methoxy-, rel- Spectrum

4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-[3-[(4aR,7aS)-hexahydro-6H-1,4-dioxino[2,3-c]pyrrol-6-yl]propoxy]-7-methoxy-, rel- rel-N-(3-Chloro-4-fluorophenyl)-6-(3-((4aR,7aS)-hexahydro-6H-[1,4]dioxino[2,3-c]pyrrol-6-yl)propoxy)-7-methoxyquinazolin-4-amine Larotinib 1438072-11-7 C24H26ClFN4O4